Valerie Dehondt: Nutritional Anemia Is Associated With Increased Risk of Severe COPD Exacerbations
Valerie Dehondt, PhD Researcher at Universiteit Gent, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in The American Journal of Clinical Nutrition, adding:
“Last week I had the opportunity to present our recently published paper on anemia at ERS congress in Barcelona, a great moment to highlight our new findings to the respiratory field!
In this study, we found that nearly 1 in 5 patients hospitalized for a severe COPD exacerbation had anemia.
Nutritional anemia, most commonly iron deficiency anemia, was the most prevalent subtype and the only subtype associated with an increased risk of readmission for a severe COPD exacerbation.
All anemia subtypes were associated with a higher mortality risk, but our findings suggest that tailored anemia treatment may help reduce this risk and represents a promising strategy to improve outcomes.
Our paper, ‘Nutritional anemia is associated with increased risk of severe COPD exacerbations: a prospective cohort study’, is now published in The American Journal of Clinical Nutrition.
Many thanks to my co-authors Nicolas Kint, Lowie Vanfleteren and Lies Lahousse for their valuable contributions to this work!”
Title: Nutritional anemia is associated with increased risk of severe COPD exacerbations: a prospective cohort study
Authors: Valerie Dehondt, Nicolas Kint, Lowie EGW Vanfleteren, Lies Lahousse
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 2, 2026, 18:08Jonathan Penm: Antithrombotic Stewardship Optimizes VTE Prophylaxis in ICU Patients
-
Nov 2, 2026, 14:48Heghine Khachatryan: Vitamin B12 Replacement Choosing the Right Route for Each Patient
-
Nov 2, 2026, 14:28Anastasia Conti: ASH Global Research Award Backs New Directions in AML Research
-
Nov 2, 2026, 14:22Sara Zalghout: Linking Bacterial Virulence to NETosis and Thromboinflammation
-
Nov 2, 2026, 13:58Functional Iron Deficiency: From Iron Sequestration to Therapeutic Targeting
-
Nov 2, 2026, 13:56Jan Terje Andersen: Albumin Engineering Opens New Routes for Erythropoietin Delivery
-
Nov 2, 2026, 13:44Rishiraj Sinha: Strengthening ISBT–AABB Collaboration in Transfusion Medicine
-
Nov 2, 2026, 13:28Jeremiah Morris: Why Blood Detection Reagents Work Better on Dry Bloodstains
-
Nov 2, 2026, 12:38Maria Τektonidou: Machine Learning – A New Approach to CVD Risk in SLE